APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  Alvim, Rafael O ^a   Freitas, Silvia Rs ^a   Ferreira, Noely E ^a   Santos, Paulo Cjl ^a   Cunha, Roberto S ^b   Mill, José G ^b   Krieger, José E ^a   Pereira, Alexandre C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LIPID;

ADULT; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; BRAZIL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERURICEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYMERASE CHAIN REACTION; PULSE WAVE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; URBAN POPULATION; URIC ACID BLOOD LEVEL; ARTERY; BLOOD; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; APOLIPOPROTEINS E; ARTERIES; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 78049479470     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-128     Document Type: Article

References (59)

1. Clinical review 141: lipids and atherosclerosis: lessons learned from randomized controlled trials of lipid lowering and other relevant studies. RA Kreisberg A Oberman, J Clin Endocrinol Metab 2002 87 2 423 437 10.1210/jc.87.2.423 11836262
2. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. AV Chobanian GL Bakris HR Black WC Cushman LA Green JL Izzo Jr DW Jones BJ Materson S Oparil JT Wright Jr, et al. Hypertension 2003 42 6 1206 1252 10.1161/01.HYP.0000107251.49515.c2 14656957 (Pubitemid 37553153)
3. Obesity, metabolic syndrome, and coronary atherosclerosis. SM Grundy, Circulation 2002 105 23 2696 2698 10.1161/01.CIR.0000020650.86137.84 12057978
4. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. LK Niskanen DE Laaksonen K Nyyssonen G Alfthan HM Lakka TA Lakka JT Salonen, Arch Intern Med 2004 164 14 1546 1551 10.1001/archinte.164.14.1546 15277287
5. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001 285 19 2486 2497 10.1001/jama.285.19.2486 11368702
6. Plasma lipoproteins: apolipoprotein structure and function. RW Mahley TL Innerarity SC Rall Jr KH Weisgraber, J Lipid Res 1984 25 12 1277 1294 6099394
7. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. YA Kesaniemi C Ehnholm TA Miettinen, J Clin Invest 1987 80 2 578 581 10.1172/JCI113107 3611358
8. Apolipoprotein E polymorphism and atherosclerosis. J Davignon RE Gregg CF Sing, Arteriosclerosis 1988 8 1 1 21 3277611
9. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. HK Das J McPherson GA Bruns SK Karathanasis JL Breslow, J Biol Chem 1985 260 10 6240 6247 3922972
10. Apolipoprotein E gene polymorphism and gender. G Kolovou D Damaskos K Anagnostopoulou DV Cokkinos, Ann Clin Lab Sci 2009 39 2 120 133 19429797
11. Localization of genes encoding apolipoproteins CI, CII, and E to the p13 - - cen region of human chromosome 19. J Scott TJ Knott DJ Shaw JD Brook, Hum Genet 1985 71 2 144 146 10.1007/BF00283370 2995235
12. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. KH Weisgraber SC Rall Jr RW Mahley, J Biol Chem 1981 256 17 9077 9083 7263700
13. Apolipoprotein E polymorphism is related to plasma lipids and apolipoproteins in Mexican adolescents. AX Medina-Urrutia GC Cardoso-Saldana J Zamora-Gonzalez YK Liria C Posadas-Romero, Hum Biol 2004 76 4 605 614 10.1353/hub.2004.0059 15754975
14. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. PW Wilson EJ Schaefer MG Larson JM Ordovas, Arterioscler Thromb Vasc Biol 1996 16 10 1250 1255 8857921
15. Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. SM Laws E Hone S Gandy RN Martins, J Neurochem 2003 84 6 1215 1236 10.1046/j.1471-4159.2003.01615.x 12614323
16. The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. P Bretsky JM Guralnik L Launer M Albert TE Seeman, Neurology 2003 60 7 1077 1081 12682309
17. Association of bone mineral density with apolipoprotein E phenotype. M Shiraki Y Shiraki C Aoki T Hosoi S Inoue M Kaneki Y Ouchi, J Bone Miner Res 1997 12 9 1438 1445 10.1359/jbmr.1997.12.9.1438 9286760
18. Association between the apolipoprotein E genotypes and breast cancer patients in Taiwanese. SJ Chang MF Hou SM Tsai JT Kao SH Wu LA Hou LY Tsai, Breast Cancer Res Treat 2006 98 1 109 113 10.1007/s10549-005-9137-0 16752225
19. Apolipoprotein E polymorphism in hemodialyzed patients and healthy controls. JA Hubacek S Bloudickova R Kubinova H Pikhart O Viklicky M Bobak, Biochem Genet 2009 47 9-10 688 693 10.1007/s10528-009-9266-y 19565203
20. Effect of polymorphisms of the MTHFR and APOE genes on susceptibility to diabetes and severity of diabetic retinopathy in Brazilian patients. FI Errera ME Silva E Yeh CM Maranduba B Folco W Takahashi AC Pereira JE Krieger MR Passos-Bueno, Braz J Med Biol Res 2006 39 7 883 888 10.1590/S0100- 879X2006000700005 16862278
21. Apolipoprotein E and coronary disease: a puzzling paradox. M Reilly DJ Rader, PLoS Med 2006 3 6 258 10.1371/journal.pmed.0030258 16729847
22. Direct phenotyping of human apolipoprotein E in plasma: application to population frequency distribution in Paris (France). S Bailleul R Couderc V Landais G Lefevre D Raichvarg J Etienne, Hum Hered 1993 43 3 159 165 10.1159/000154172 8330879
23. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol 1988 41 2 105 114 10.1016/0895-4356(88)90084-4 3335877
24. Epidemiologia da hipertenso arterial na cidade de Vitária, Espírito Santo. JGMM Mill IO Silva AL Marquezine AVL Ferreira RS Cunha, et al. Hipertenso 2004 7 3 109 116
25. World Health Organization. Obesity and overweight. http://www.who.int/ mediacentre/factsheets/fs311/en/index.html
26. Association of alpha1a-adrenergic receptor polymorphism and blood pressure phenotypes in the Brazilian population. SR Freitas AC Pereira MS Floriano JG Mill JE Krieger, BMC Cardiovasc Disord 2008 8 40 10.1186/1471-2261-8-40 19105822
27. [Race, compliance to treatment and/or consultation and control of arterial hypertension]. I Lessa J Fonseca, Arq Bras Cardiol 1997 68 6 443 449 9515252
28. -1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999 17 2 151 183 10067786
29. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. R Asmar A Benetos J Topouchian P Laurent B Pannier AM Brisac R Target BI Levy, Hypertension 1995 26 3 485 490 7649586
30. Endothelial nitric oxide synthase gene variant modulates the relationship between serum cholesterol levels and blood pressure in the general population: new evidence for a direct effect of lipids in arterial blood pressure. AC Pereira AC Sposito GF Mota RS Cunha FL Herkenhoff JG Mill JE Krieger, Atherosclerosis 2006 184 1 193 200 10.1016/j.atherosclerosis.2005.03.035 15916766
31. [III Brazilian Guidelines on Dyslipidemias and Guideline of Atherosclerosis Prevention from Atherosclerosis Department of Sociedade Brasileira de Cardiologia]. RD Santos, Arq Bras Cardiol 2001 77 Suppl 3 1 48 11781591
32. A simple salting out procedure for extracting DNA from human nucleated cells. SA Miller DD Dykes HF Polesky, Nucleic Acids Res 1988 16 3 1215 10.1093/nar/16.3.1215 3344216
33. Apolipoprotein E, angiotensin-converting enzyme and kallikrein gene polymorphisms and the risk of Alzheimer's disease and vascular dementia. HK Wang HC Fung WC Hsu YR Wu JC Lin LS Ro KH Chang FJ Hwu Y Hsu SY Huang, et al. J Neural Transm 2006 113 10 1499 1509 10.1007/s00702-005-0424-z 16465461
34. A polymorphism of apolipoprotein E (APOE) gene is associated with age at natural menopause in Caucasian females. LN He RR Recker HW Deng V Dvornyk, Maturitas 2009 62 1 37 41 10.1016/j.maturitas.2008.10.011 19058936
35. APOE genotype, lipids, and coronary heart disease risk: a prospective population study. H Ward PN Mitrou R Bowman R Luben NJ Wareham KT Khaw S Bingham, Arch Intern Med 2009 169 15 1424 1429 10.1001/archinternmed.2009.234 19667307
36. Apolipoprotein E polymorphism in normal Han Chinese population: frequency and effect on lipid parameters. S Liang M Pan HH Geng H Chen LQ Gu XT Qin JJ Qian JH Zhu CF Liu, Mol Biol Rep 2009 36 6 1251 1256 10.1007/s11033-008-9305-5 18600472
37. Association of apolipoprotein E polymorphism with plasma lipids and Alzheimer's disease in a Southern Brazilian population. FM de-Andrade M Larrandaburu SM Callegari-Jacques G Gastaldo MH Hutz, Braz J Med Biol Res 2000 33 5 529 537 10.1590/S0100-879X2000000500007 10775884
38. Apolipoprotein E polymorphism in Brazilian dyslipidemic individuals: Ouro Preto study. A Mendes-Lana GG Pena SN Freitas AA Lima RL Nicolato RM Nascimento-Neto GL Machado-Coelho RN Freitas, Braz J Med Biol Res 2007 40 1 49 56 10.1590/S0100-879X2007000100007 17224996
39. Apolipoprotein E polymorphism and its association with serum lipid levels in Brazilian children. E De Franca JG Alves MH Hutz, Hum Biol 2004 76 2 267 275 10.1353/hub.2004.0030 15359535
40. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels. S Saidi LB Slamia SB Ammou T Mahjoub WY Almawi, J Stroke Cerebrovasc Dis 2007 16 4 160 166 10.1016/j.jstrokecerebrovasdis.2007.03.001 17689412
41. Apolipoprotein E gene polymorphisms in patients with premature myocardial infarction: a case-controlled study in Asian Indians in North India. P Kumar K Luthra M Dwivedi VK Behl RM Pandey A Misra, Ann Clin Biochem 2003 40 Pt 4 382 387 10.1258/000456303766477020 12880539
42. Apolipoprotein E polymorphism is not associated with lipid levels and coronary artery disease in Greek patients with familial hypercholesterolaemia. C Pitsavos DM Choumerianou J Skoumas S Maumus C Stefanadis GV Dedoussis S Visvikis-Siest, Clin Exp Med 2005 5 4 196 201 10.1007/s10238-005-0086-z 16362800
43. Association among oxidized LDL levels, MnSOD, apolipoprotein E polymorphisms, and cardiovascular risk factors in a south Brazilian region population. MG Gottlieb CH Schwanke AF Santos PF Jobim DP Mussel IB da Cruz, Genet Mol Res 2005 4 4 691 703 16475114
44. Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes. TA Miettinen H Gylling H Vanhanen A Ollus, Arterioscler Thromb 1992 12 9 1044 1052 1525119
45. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. MS Weintraub S Eisenberg JL Breslow, J Clin Invest 1987 80 6 1571 1577 10.1172/JCI113243 3479440
46. Aortic pulse wave velocity predicts cardiovascular mortality in subjects 70 years of age. S Meaume A Benetos OF Henry A Rudnichi ME Safar, Arterioscler Thromb Vasc Biol 2001 21 12 2046 2050 10.1161/hq1201.100226 11742883 (Pubitemid 34219760)
47. Hyperlipidemia in the hypertensive patient. A Zanchetti, Am J Med 1994 96 6A 3S 8S 10.1016/0002-9343(94)90225-9 8017463
48. Abnormalities of lipid metabolism and arterial rigidity in young subjects with borderline hypertension. BM Pannier MS Cambillau V Vellaud V Atger N Moatti ME Safar, Clin Invest Med 1994 17 1 42 51 8174314
49. Association of ApoE polymorphisms with prevalent hypertension in 1406 older adults: the Bambui Health Aging Study (BHAS). AK Fuzikawa SV Peixoto M Taufer EH Moriguchi MF Lima-Costa, Braz J Med Biol Res 2008 41 2 89 94 10.1590/S0100-879X2008000200002 18297189
50. [Influence of the APOE genotypes in some atherosclerotic risk factors]. M Carmo Martins L Lima Faleiro MO Rodrigues I Albergaria A Fonseca, Acta Med Port 2008 21 5 433 440 19187685
51. Cholesterol, cholesterol lowering, and endothelial function. RA Vogel MC Corretti J Gellman, Prog Cardiovasc Dis 1998 41 2 117 136 10.1016/S0033-0620(98) 80008-X 9790413
52. Relationship of obesity to serum triglyceride, cholesterol, and uric acid, and to plasma-glucose levels. LE Hollister JE Overall HL Snow, Am J Clin Nutr 1967 20 7 777 782 6036267
53. Serum uric acid is associated with metabolic risk factors for cardiovascular disease in the Uygur population. NF Li HM Wang J Yang L Zhou XG Yao J Hong, Appl Physiol Nutr Metab 2009 34 6 1032 1039 10.1139/H09-101 20029511
54. Effect of apolipoprotein E polymorphism on serum uric acid levels in healthy subjects. EN Liberopoulos GA Miltiadous VG Athyros M Ganotakis M Cariolou E Bairaktari MS Elisaf, J Investig Med 2005 53 3 116 122 10.2310/6650.2005.00306 15921030
55. Effect of insulin on uric acid excretion in humans. A Quinones Galvan A Natali S Baldi S Frascerra G Sanna D Ciociaro E Ferrannini, Am J Physiol 1995 268 1 Pt 1 1 5 7840165
56. Apolipoprotein E gene polymorphism and obesity status in middle-aged men with coronary heart disease. GD Kolovou KK Anagnostopoulou P Kostakou V Giannakopoulou C Mihas G Hatzigeorgiou IK Vasiliadis DP Mikhailidis DV Cokkinos, In Vivo 2009 23 1 33 39 19368122
57. Influence of apolipoprotein E polymorphisms on serum creatinine levels and predicted glomerular filtration rate in healthy subjects. EN Liberopoulos GA Miltiadous M Cariolou R Kalaitzidis KC Siamopoulos MS Elisaf, Nephrol Dial Transplant 2004 19 8 2006 2012 10.1093/ndt/gfh349 15187200
58. Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice. I Karagiannides R Abdou A Tzortzopoulou PJ Voshol KE Kypreos, FEBS J 2008 275 19 4796 4809 10.1111/j.1742-4658.2008.06619.x 18754772
59. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype. KE Kypreos X Li KW van Dijk LM Havekes VI Zannis, Biochemistry 2003 42 33 9841 9853 10.1021/bi0271796 12924933